Thought i'd bring back this thread as futurenow seems to have worked out where this is going.
IMO we are getting closer to hitting the Asian market with our products. With EBOS and Zuellig showcasing us, this could be huge once our expansion in the Asian market starts hitting our bottom line. Maybe we are allot closer than what everyone expects and some smart money getting in?
IMO this SP could double this year.
Also is ithis a case of when does MDR get taken out?
Should be an interesting year.
Ann: MedAdvisor to launch in Asia with Zuellig Pharma, page-18
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.005(1.72%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $84.31K | 299.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 209547 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 94066 | 1 |
View Market Depth
| Last trade - 12.52pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
